The high prevalence of infectious diseases worldwide, speedily growing geriatric population, growing demand for point-of-care testing, and increased use of rapid testing in-home care settings are boosting the growth of the

Global Lateral Flow Assay Market was valued US$ 5.8 Bn in 2017 and is expected to reach US$ 10.63 Bn by 2026, at a CAGR of 7.87 % during a forecast period.